Lyell Immunopharma, Inc. (LYEL) Insider Trading

Name: Lyell Immunopharma, Inc. (LYEL) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 10, 2026): David Shook (Chief Medical Officer): Sale of 500 shares, $6.3K.

Get alerted when insiders trade LYEL

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta